Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 061250124 approvals1 trials

HWAIL PHARM. CO., LTD

Official website

Founded in 1980 and listed on the KOSDAQ in 2002, Hwail Pharm specializes in active pharmaceutical ingredients and cephalosporin antibiotic finished drugs.

As of 2026-10-11, HWAIL PHARM. CO., LTD has 124 Korean MFDS drug approvals on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Products & technology

  • Active and inactive pharmaceutical ingredients (API/IPI)Raw materials for cardiovascular, antibacterial, gastrointestinal, respiratory, and anticancer drugs
  • Cephalosporin antibioticsFinished pharmaceutical (beta-lactam antibiotic)
  • Functional health food ingredients (red ginseng, aloe, ginseng, etc.)Health functional food ingredient

Regulatory approvals

data.go.kr

124 Korean MFDS drug approvals · 2002–2022

  • MFDS drugDaparsi Tab 10/100mg2022-01-12
    Drug · Prescription · Approval202200214
  • MFDS drugAtoeve Tab. 10/10mg2021-01-08
    Drug · Prescription · Approval202100227
  • MFDS drugAtoeve Tab. 10/40mg2021-01-08
    Drug · Prescription · Approval202100228
  • MFDS drugAtoeve Tab. 10/20mg2021-01-08
    Drug · Prescription · Approval202100229
  • MFDS drugHIALPHA Inj.2020-05-26
    Drug · Prescription · Approval202003838
  • MFDS drugTenodi tab.Revoked2020-01-08
    Drug · Prescription · Approval202000141
  • MFDS drugYouthcaine Cream(Lidicaine)2019-12-03
    Drug · OTC · Notification201908217
  • MFDS drugTernarine tabRevoked2019-11-20
    Drug · Prescription · Approval201908005
  • MFDS drugIrso tab.Revoked2019-11-11
    Drug · Prescription · Approval201907861
  • MFDS drugDagli-M Tab.Revoked2019-11-06
    Drug · Prescription · Approval201907770
  • MFDS drugSolifeni tab. 5mgRevoked2019-11-04
    Drug · Prescription · Approval201907703
  • MFDS drugSolifeni tab. 10mgRevoked2019-11-04
    Drug · Prescription · Approval201907704
Show 68 more
  • MFDS drugEso-MP Tab. 20mg2019-10-28
    Drug · Prescription · Approval201907479
  • MFDS drugEso-MP Tab. 40mg2019-10-28
    Drug · Prescription · Approval201907480
  • MFDS drugEscier tab. 20mgRevoked2019-10-18
    Drug · Prescription · Approval201907344
  • MFDS drugEscier tab. 10mgRevoked2019-10-18
    Drug · Prescription · Approval201907345
  • MFDS drugSuvatin Tab. 20mgRevoked2019-10-18
    Drug · Prescription · Approval201907349
  • MFDS drugHwacilta tab.Revoked2019-10-16
    Drug · Prescription · Approval201907279
  • MFDS drugHwalonal CR tab. 0.2mgRevoked2019-10-16
    Drug · Prescription · Approval201907283
  • MFDS drugFamoti Tab. 20mg2019-10-15
    Drug · Prescription · Approval201907237
  • MFDS drugBytarin tab. 10/20mgRevoked2019-10-15
    Drug · Prescription · Approval201907233
  • MFDS drugBytarin tab. 10/10mgRevoked2019-10-15
    Drug · Prescription · Approval201907234
  • MFDS drugExatin cap. 150mgRevoked2019-10-10
    Drug · Prescription · Approval201907154
  • MFDS drugAllestin Tab. 20mgRevoked2019-09-24
    Drug · Prescription · Approval201906695
  • MFDS drugSarpogre tab. 100mg2019-09-19
    Drug · Prescription · Approval201906564
  • MFDS drugRtos tab.Revoked2019-09-09
    Drug · Prescription · Approval201906370
  • MFDS drugEclofen CR Tab.2019-08-29
    Drug · Prescription · Approval201906178
  • MFDS drugNellcure nail lacquerRevoked2019-08-23
    Drug · OTC · Notification201905979
  • MFDS drugRivero cap. 3.0mgRevoked2019-08-07
    Drug · Prescription · Approval201905591
  • MFDS drugRivero cap. 1.5mgRevoked2019-08-07
    Drug · Prescription · Approval201905592
  • MFDS drugIrion tab. 10mgRevoked2019-07-18
    Drug · Prescription · Approval201904819
  • MFDS drugHwail tami cap. 30mgRevoked2019-07-17
    Drug · Prescription · Approval201904790
  • MFDS drugHwail tami cap. 45mgRevoked2019-07-17
    Drug · Prescription · Approval201904791
  • MFDS drugHwail tami cap. 75mgRevoked2019-07-17
    Drug · Prescription · Approval201904792
  • MFDS drugMemansa Tab. 10mg2019-06-04
    Drug · Prescription · Approval201903733
  • MFDS drugTelmilepine Tab. 80/5mg2019-05-21
    Drug · Prescription · Approval201903294
  • MFDS drugTelmilepine Tab. 40/5mg2019-05-21
    Drug · Prescription · Approval201903295
  • MFDS drugRebarid Tab. 100mg2019-04-23
    Drug · Prescription · Approval201902535
  • MFDS drugFinaseta Tab. 5mg2019-04-17
    Drug · Prescription · Approval201902353
  • MFDS drugFinaseta Tab. 1mgRevoked2019-03-29
    Drug · Prescription · Approval201901938
  • MFDS drugFloxen Cap.2018-12-20
    Drug · Prescription · Approval201805198
  • MFDS drugFloxen Cap. 10mgRevoked2018-12-20
    Drug · Prescription · Approval201805197
  • MFDS drugTopirai Tab. 100mg2018-10-31
    Drug · Prescription · Approval201804314
  • MFDS drugTopirai Tab. 25mg2018-10-31
    Drug · Prescription · Approval201804315
  • MFDS drugHwamocle Tab. 375mg2018-09-27
    Drug · Prescription · Approval201803807
  • MFDS drugHwail Cefotaxime Sodium Inj. 1g2018-09-20
    Drug · Prescription · Notification201803771
  • MFDS drugEldosteine Cap.2018-08-28
    Drug · OTC · Notification201803487
  • MFDS drugFreshview Beta2016-08-23
    Drug · OTC · Notification201605059
  • MFDS drugZincete Tab. 250mg2016-03-09
    Drug · Prescription · Approval201601374
  • MFDS drugHwamocle Tab. 625mg2015-12-31
    Drug · Prescription · Approval201508548
  • MFDS drugDoneone Tab 5mg2015-12-28
    Drug · Prescription · Approval201508435
  • MFDS drugDoneone Tab. 10mg2015-12-28
    Drug · Prescription · Approval201508436
  • MFDS drugSuvatin Tab. 10mg2015-12-28
    Drug · Prescription · Approval201508442
  • MFDS drugHwatiren Tab.Revoked2015-11-23
    Drug · Prescription · Notification201507801
  • MFDS drugMosagood Tab.2015-11-05
    Drug · Prescription · Approval201507615
  • MFDS drugAmlobesil 5mg2015-08-24
    Drug · Prescription · Approval201505922
  • MFDS drugRabetop Tab. 10mg2015-07-29
    Drug · Prescription · Approval201505133
  • MFDS drugRabetop Tab. 20mg2015-07-29
    Drug · Prescription · Approval201505134
  • MFDS drugNewbrex Cap. 200mg2015-06-29
    Drug · Prescription · Approval201504176
  • MFDS drugHwaroxo tab.2015-05-15
    Drug · Prescription · Approval201502959
  • MFDS drugAlgi-A sol.2015-03-31
    Drug · Prescription · Notification201501701
  • MFDS drugTendanamin Cap.2015-02-09
    Drug · OTC · Notification201500662
  • MFDS drugEntevir tab. 0.5mg2014-07-30
    Drug · Prescription · Approval201403512
  • MFDS drugEntevir tab. 1.0mgRevoked2014-07-30
    Drug · Prescription · Approval201403511
  • MFDS drugHwail levofloxacin ophthalmic(levofloxacin)2014-07-14
    Drug · Prescription · Notification201403115
  • MFDS drugHwail cefotiam inj. 1g2014-07-10
    Drug · Prescription · Notification201403089
  • MFDS drugLoxical Cap.2014-05-28
    Drug · Prescription · Approval201402419
  • MFDS drugEporin Tab.2014-05-26
    Drug · Prescription · Approval201402374
  • MFDS drugAbatin Tab. 20mg2014-03-18
    Drug · Prescription · Approval201401233
  • MFDS drugNotongpen plus mini Tab.2013-12-04
    Drug · Prescription · Approval201310500
  • MFDS drugFulocan cap.2013-11-15
    Drug · Prescription · Approval201310137
  • MFDS drugHwail Roxithromycin Tab.2013-10-10
    Drug · Prescription · Approval201309610
  • MFDS drugEclopen Tab.2013-09-30
    Drug · Prescription · Approval201309500
  • MFDS drugOflar Tab.2013-09-23
    Drug · Prescription · Approval201309390
  • MFDS drugDagli Tab2013-07-31
    Drug · Prescription · Approval201308597
  • MFDS drugAbatin Tab. 10mg2013-07-19
    Drug · Prescription · Approval201308307
  • MFDS drugLesunny Tab.2013-05-14
    Drug · Prescription · Approval201307338
  • MFDS drugMediron Tab.2013-01-25
    Drug · Prescription · Approval201302240
  • MFDS drugCloje Tab.2013-01-18
    Drug · Prescription · Approval201301620
  • MFDS drugCophemin soft cap.Revoked2012-03-14
    Drug · OTC · Notification201201600

Showing the 80 most recent of 124 records.

Clinical trials

data.go.kr

1 MFDS clinical trial authorisations · 2014 (Bioequivalence 1)

  • Bioequivalence메디론정(메틸프레드니솔론)2014-05-26

    2 trial sites

R&D and key agreements

Source: DART corporate disclosure

의약품 원료 및 건강기능식품 개발 · The in-house research institute at the Pangyo office (Korea Bio Park Building C, 5th floor) develops pharmaceutical ingredients, including for new drugs, and health functional foods, with a research staff of 7, including 1 PhD and 6 master's degree holders.

Key disclosures

KRX KIND via OpenDART

Patents

KIPRIS · applicant-matched
Show 12 more patents

AI reads

MAA server logs · IP-verified
63
Times AI engines pulled HWAIL PHARM. CO., LTD's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

1
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

62
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

13
live 1
Last 7 days
50
live 1
Last 30 days
63
live 1
All time
  • OpenAIChatGPT-Userlive1
  • OpenAIOAI-SearchBot57
  • PerplexityPerplexityBot2
  • AnthropicClaudeBot2
  • GoogleGoogleOther1

Measured since Aug 27, 2026 · 4 AI engines · last read Oct 10, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for HWAIL PHARM. CO., LTD and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies in the same categoryPharma & CDMO

ILDONG HOLDINGS CO.,LTD100

Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.

Yuyu Pharma, Inc.100

Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.

IL DONG PHARMACEUTICAL CO., LTD.100

Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.

Medy-Tox Inc.99

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

GC Biopharma Corp.97

KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.

DAEWON PHARMACEUTICAL CO.,LTD85

KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.

SAMSUNG BIOLOGICS CO.,LTD.85

Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.

GENOLUTION INC.85

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

AHN-GOOK PHARMACEUTICAL Co., Ltd.85

Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.

CORESTEMCHEMON Inc.85

Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.

BIO-FD&C CO.,LTD.85

Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.

HANDOK Inc.85

KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition